Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Seres Therapeutics hired Tom DesRosier as chief legal officer and executive vice president. Most recently, he was chief legal and administrative officer at Ariad Pharmaceuticals, and before that, he was chief legal officer at Cubist Pharmaceuticals. Previously, he worked at Sanofi as senior vice president and general counsel, North America.
Intrexon hired Geno Germano as president;
Sanofi hired Rita Balice-Gordon as head of neurobiology research;
ALK hired Carsten Hellmann as chief executive officer and president;
Novartis hired Paul Hudson to head its pharmaceuticals unit;
Novartis named Bruno Strigini to run its oncology unit;
Novartis said that David Epstein, who ran the pharmaceutical division, is leaving;
XBiotech hired Dawn McCollough as vice president of clinical operations;
Relmada Therapeutics promoted Michael Becker to chief financial officer;
Mauna Kea Technologies hired Pierre Forest as chief operating officer;
Fate Therapeutics hired Dr. Chris Storgard as chief medical officer;
Codiak BioSciences hired Jan Lotvall as chief scientist.
About the Author Reprints
